skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Angiotensin (1-7)/Mas receptor axis activation ameliorates the changes in fatty acid composition in diabetic rats with nephropathy

Original Research

(1541) Views  (412) Full article downloads

Authors: Kulwinder Singh, Tajinder Singh, PL Sharma

Published Date November 2010 Volume 2010:2 Pages 163 - 168
DOI: http://dx.doi.org/10.2147/JEP.S14342

Kulwinder Singh*, Tajinder Singh*, PL Sharma
Department of Pharmacology, ISF College of Pharmacy, Moga India; *These authors contributed equally to this work

Abstract: Diabetes mellitus is often associated with altered fatty acids composition. This study was designed to investigate the role of angiotensin (Ang) (1-7)/Mas receptor in improving fatty acids composition in streptozotocin (STZ)-induced diabetic nephropathy (DN) in rats. Rats treated with STZ (50 mg/kg, i.p. once) developed DN after 8 weeks. Fatty acid composition was estimated in renal cortical tissue by gas chromatography. Treatment with Ang (1-7), A-779, and Ang (1-7) plus A-779 was given from week 4 to week 8. Diabetic rats exhibited a significant increase in levels of saturated fatty acids and a significant decrease in levels of polyunsaturated fatty acids (PUFAs). Treatment with Ang (1-7) significantly attenuated these diabetes-induced changes. In diabetic rats, prior administration of A-779 significantly attenuated the increase in PUFAs produced by Ang (1-7); however, for saturated fatty acids, A-779 significantly blocked the decrease in palmitic acid only. Our study, for the first time, documented that endogenous Ang (1-7) modulates fatty acid composition in rats. Further, treatment with Ang (1-7) significantly attenuated diabetes-induced changes in fatty acids composition. This may be an additional mechanism implying the renoprotective role of Ang (1-7) in diabetic rats.

Keywords: diabetic nephropathy, fatty acids, Mas receptor






Readers of this article also read:

Manifestation of renal disease in obesity: pathophysiology of obesity-related dysfunction of the kidney
Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose–insulin homeostasis in animal models
Potential antidiabetic and antioxidant activities of Morus indica and Asystasia gangetica in alloxan-induced diabetes mellitus
Cardioprotective and β-adrenoceptor antagonistic activity of a newly synthesized aryloxypropanolamine derivative PP-36
Effect of amlodipine, a calcium channel antagonist, on gonadal steroid of male wistar albino rats
New standards in hypertension and cardiovascular risk management: focus on telmisartan
Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats
Restoration of renal hemodynamics and functions during black cumin (Nigella sativa) administration in streptozotocin-induced diabetic rats
Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials
Proteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University